Harsh Vardhan

Harsh Vardhan

Auto-generated profile, based on publicly available information

Harsh Vardhan

Department of Nephrology, Patna Medical College, All India Institute of Medical Sciences, Patna, Bihar, India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in DNA and Cell Biology
Verified
Journal Article
Closed access
PSPragya Srivastava
Pragya Srivastava
HVHarsh Vardhan
Harsh Vardhan
ABApurb Rashmi Bhengraj
Apurb Rashmi Bhengraj
RJRajneesh Jha
Rajneesh Jha
LSLaishram Chandreshwor Singh
Laishram Chandreshwor Singh
AMAruna Mittal
Aruna Mittal
Epidemiological and animal model studies suggest that sequelae of genital Chlamydia trachomatis infection are more often associated with second or subsequent infections than with initial infection. Further, in order to establish an acute or long-term persistent infection, C. trachomatis develops several strategies to circumvent host immune responses. Hence, resolution of the C. trachomatis infection may require modulation of host factors especially during persistent or chronic infection. Moreover, azithromycin treatment has been reported to possess anti-inflammatory properties but its mechanism of action is still not elucidated. Therefore, in order to better understand the effect of azithromycin in chronic conditions, our aim was to study changes in expression of key genes associated with inflammatory cytokines and receptors, mitogen-activated protein kinase (MAPK) signaling pathway, and apoptosis pathway before and after therapy with azithromycin in infertile women with recurrent C. trachomatis infection. Real-time polymerase chain reaction was performed to study inflammatory cytokines and receptors, MAPK signaling pathway, and apoptosis pathway before and after therapy with azithromycin in infertile women with recurrent C. trachomatis infection. Further, effect of azithromycin on activation of extracellular signal-regulated kinase was studied in epithelial cells by western blotting. Chemokine (C-C motif) ligand 2 (CCL2), CCL5, chemokine (C-X-C motif) ligand 1 (CXCL1), CXCL5, CXCL9, interleukin-1B (IL-1B), IL-8, baculoviral IAP repeat-containing 3 (BIRC3), myeloid cell leukemia sequence 1 (MCL1), and MAPK1 were downregualted after azithromycin treatment. In addition, phosphorylation of extracellular signal-regulated kinase was inhibited after azithromycin treatment in epithelial cells obtained from women with recurrent infection. Hence, our data suggest that azithromycin with its properties apart from antibacterial activity may contribute to its therapeutic potential in treatment of chronic recurrent infection in infertile women.

Verified
Journal Article
Open access
DRDeependra Rai
Deependra Rai
AHAmeet H
Ameet H
PLPallavi Lohani
Pallavi Lohani
SPSanjay Pandey
Sanjay Pandey
HVHarsh Vardhan
Harsh Vardhan
Introduction: This retrospective observational study has been designed to identify clinical characteristics, treatment outcomes and factors associated with severe illness in 813 COVID-19 patients hospitalised in an Indian tertiary care hospital. Material and Methods: This was a retrospective analysis of patient admitted between 1 July to 15 August 2020 with COVID-19 infections. Logistic regression was performed to explore the association of clinical characteristics and laboratory parameters with the risk of severe disease and mortality. The statistical significance level was set at 0.05 (two-tailed). Results: Out of 813 study patients, 630 (77.50%) patients were categorised with mild to moderate while 183 (22.50%) patients as severe Covid infection. Mortality was significantly higher in severe Covid patients as compared to mild moderate cases (66.21% vs. 10.31%. p < 0.0001. Patients with severe infection were significantly more likely to have diabetes hypertension, chronic kidney disease (CKD) and had significantly higher Neutrophil count, serum creatinine, C-reactive protein (CRP), ferritin, D-Dimer and decreased haemoglobin, lymphocyte and serum calcium than patients with mild-moderate infection. In Multivariate analy-sis, age more than 60 years [AOR: 2.114, 95% CI (1.05–4.254), 0.036], NLR more than 3.3 [AOR: 1.082, 95% CI (1.030–1.137), 0.002] and D-Dimer >1 μg/mL [AOR: 2.999 (1.464–6.146), 0.003] were found significantly associated with severe disease (p < 0.05). Factors associated with mortality were age more than 60 years, presence of breathlessness, severe disease or presence of chronic kidney disease. Conclusions: Factors like elderly age (age > 60 years), elevated NRL, CRP, D-Dimer and serum ferritin were associated with sig-nificantly higher risk to develop severe COVID-19 infections. Elderly, and patients with CKD were associated with worse outcome.

29 June 2024 in Indian Journal of Nephrology
Verified
Journal Article
Open access
SSShyama Shyama
Shyama Shyama
HVHarsh Vardhan
Harsh Vardhan
VOVishnu Shankar Ojha
Vishnu Shankar Ojha
RBRatnadeep Biswas
Ratnadeep Biswas
SAShamshad Ahmad
Shamshad Ahmad
AKAmit Kumar
Amit Kumar
The emergence of COVID-19 triggered a global health crisis, sparking concerns within the medical community about its interaction with chronic kidney disease (CKD) and the heightened vulnerability of individuals with compromised renal function to severe viral infection and mortality. This retrospective study encompassed all adult patients with laboratory-confirmed COVID-19 and pre-existing CKD admitted between May 2020 and May 2023. Their demographic data, relevant clinical parameters, and laboratory values were collected. Kaplan-Meier curve analysis and Log Rank test were employed to compare survival times between CKD patients and those developing acute kidney injury (AKI), while Cox regression analyses were conducted to pinpoint factors influencing the hazard of a fatal outcome. The study, involving 150 COVID-19 patient records with pre-existing CKD, revealed that male gender, advanced age, requirement for invasive ventilation, and elevated levels of inflammatory markers such as total leukocyte count, lactate dehydrogenase, C-reactive protein, D-dimer, and IL-6 significantly increased the risk of death. These findings underscore the necessity for tailored care and meticulous management in COVID-19 patients with coexisting CKD, emphasizing the importance of addressing factors such as gender, age, and inflammatory status to mitigate mortality risks effectively.